Discover relevant content from across the suite of ALM legal publications
From the Industry
More content from ThinkAdvisor and select sponsors
Investment Advisor Issue Gallery
Read digital editions of Investment Advisor Magazine
Tax Facts
Get clear, current, and reliable answers to pressing tax questions
Copyright © 2024 ALM Global, LLC. All Rights Reserved.
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
April 01, 2010 at 08:00 PM
Sales of medications were up 5.1% in 2009, to over $300 billion, from a 2008 growth rate of 1.8%, a market research firm reports.
The arrival of new drugs for cancer, thrombosis and other diseases were a main reason for the increase, according to IMS Health, Norwalk, Conn., which conducted the study. Meanwhile, the arrival of lower-cost generic drugs for epilepsy, migraine, and other disorders helped moderate the rise in costs, IHS said.
Top-selling medication categories in 2009 were antipsychotics, with sales of $14.6 billion, equal to the 2008 level; lipid regulators, with sales of over $13 billion, down 10% from 2008 levels; proton pump inhibitors, $13.6 billion, down 2% year over year; and antidepressants, growing 3% to $9.9 billion.
Generic products now represent 75% of all dispensed prescriptions in the U.S., up from 57% percent in 2004, IMS reported.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Copyright © 2024 ALM Global, LLC. All Rights Reserved.
Podcast Center
Video Center
Webcasts
Resource Center
Events
